Filter
4041
Text search:
drug
therapy
Featured
Recommendations
381
New Publications
998
Language
Document type
No document type
2516
Guidelines
562
Studies & Reports
541
Manuals
161
Strategic & Response Plan
88
Fact sheets
69
Training Material
56
Situation Updates
15
Infographics
13
Resource Platforms
9
Brochures
5
App
1
Online Courses
1
Countries / Regions
India
273
Global
115
Kenya
114
South Africa
107
Uganda
91
Western and Central Europe
85
Ethiopia
79
Tanzania
78
Nigeria
74
Zambia
69
Nepal
63
Africa
58
Malawi
57
Eastern Europe
56
Sierra Leone
50
Ukraine
50
Latin America and the Carribbean
48
Liberia
47
Ghana
47
Namibia
46
Rwanda
42
Myanmar / Burma
38
Asia
37
Bangladesh
36
Russia
36
Indonesia
32
Zimbabwe
31
Lesotho
30
Philippines
29
Cambodia
27
South–East Asia Region
21
Germany
17
Botswana
17
Senegal
16
Eswatini/ Swaziland
15
Mozambique
14
Cameroon
11
Syria
11
Brazil
11
Congo, Democratic Republic of
10
Haiti
10
East and Southern Africa
10
Tajikistan
10
USA
9
Albania
9
Thailand
8
Colombia
8
West and Central Africa
7
Middle East and North Africa
7
Eastern Europe and Central Asia
7
Venezuela
7
Burkina Faso
6
Pakistan
6
South Sudan
6
China
6
Western Pacific Region
6
Georgia
6
Vietnam
6
Benin
5
Argentina
5
Peru
5
Armenia
5
Guinea
4
Iraq
4
Afghanistan
4
Sudan
4
North Macedonia
4
Paraguay
4
Laos
4
Timor Leste/ East Timor
4
Moldova
4
United Kingdom
4
Spain
4
Somalia
3
Switzerland
3
Bolivia
3
Sri Lanka
3
Estonia
3
North America
3
Jamaica
3
Saudi Arabia
2
Jordan
2
Lebanon
2
Turkey
2
Papua New Guinea
2
Central African Republic
2
Angola
2
Yemen
2
Bhutan
2
Poland
2
Canada
2
Iran
2
Kyrgyzstan
2
Kazakhstan
2
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Gambia
1
Malaysia
1
Ireland
1
Singapore
1
Austria
1
Serbia
1
Hungary
1
Ecuador
1
Greece
1
Libya
1
Madagascar
1
Mexico
1
Chile
1
Fiji
1
Solomon Islands
1
Palestine
1
North Korea
1
Southern Africa
1
Qatar
1
Lithuania
1
Gabon
1
Turkmenistan
1
Denmark
1
Belgium
1
France
1
Tunisia
1
Portugal
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
1499
Clinical Guidelines
427
Public Health
178
Women & Child Health
130
Key Resources
67
Capacity Building
59
Pharmacy & Technologies
36
Toolboxes
HIV
693
TB
481
Mental Health
395
AMR
158
NTDs
155
COVID-19
124
Pharmacy
104
NCDs
102
Caregiver
70
Malaria
52
Ebola & Marburg
44
Disability
38
Refugee
38
Conflict
30
Rapid Response
29
Global Health Education
24
Planetary Health
20
Health Financing Toolbox
17
Polio
16
Cholera
14
Zika
10
Specific Hazards
10
2.0 Rapid Response
8
Natural Hazards
6
Social Ethics
4
These policy guidelines provide a strategic approach and new recommendations for integrated TB and HIV services for patients suffering from substance-abuse addiction. The key recommendations fall under three main categories: joint planning, key interventions, and overcoming barriers.
Clinical Infectious Diseases
1586 - 1594 • CID 2016:62 (15 June) • HIV/AIDS
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Meeting Report 27-29 October 2020
The overall goal of the meeting was to discuss recent changes in treatment regimens and diagnostics for drug-resistant TB and to determine how these impact on the definition of XDR-TB, with a view to revising this
...
PLOS ONE | https://doi.org/10.1371/journal.pone.0192068 March 9, 2018
with recommended essential medicines for common diseases in patients in Stockholm County Council (Healthcare Region), Sweden
Introduction Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan
Africa. In Malawi, a PV enhancement initiative was introduced to address major barriers to PV.
Objective The objective of this initi
...
Science Spotlight
February 14, 2018
Emergence of antimicrobial resistance is a result of the use, overuse and misuse of antibiotics both in humans and animals. In Ethiopia, there are indications on the misuse of antibiotics by health care providers’, unskilled practitioners, and drug
...